AP-2δ Is a Crucial Transcriptional Regulator of the Posterior Midbrain by Hesse, Katrin et al.
AP-2d Is a Crucial Transcriptional Regulator of the
Posterior Midbrain
Katrin Hesse
1., Kristina Vaupel
2., Simone Kurt
3, Reinhard Buettner
4, Jutta Kirfel
1, Markus Moser
2*
1Institute of Pathology, University of Bonn, Bonn, Germany, 2Max-Planck-Institute of Biochemistry, Martinsried, Germany, 3Institute of Neurobiology, University Ulm,
Ulm, Germany, 4Institute of Pathology, University of Koeln, Koeln, Germany
Abstract
Ap-2 transcription factors comprise a family of 5 closely related sequence-specific DNA binding proteins that play pivotal
and non-redundant roles in embryonic organogenesis. To investigate the function of Ap-2d,w de analyzed its expression
during embryogenesis and generated Ap-2d-deficient mice. In line with the specific expression pattern of Ap-2d in the
mesencephalic tectum and the dorsal midbrain, Ap-2d-deficient mice failed to maintain the colliculus inferior, a derivative of
the dorsal midbrain, as a consequence of increased apoptotic cell death. To identify specific Ap-2d target genes in cells of
the developing dorsal midbrain, we performed whole genome analysis of cDNA expression levels. This approach identified a
set of 12 putative target genes being expressed in the developing midbrain, including the transcription factors Pitx2, Mef2c,
Bhlhb4 and Pou4f3. Using chromatin immunoprecipitation (CHIP) we showed that some of these genes are direct targets of
Ap-2d. Consistently, we demonstrate that Ap-2d occupies and activates the Pou4f3 and Bhlhb4 promoters. In addition,
known Pou4f3 target genes were downregulated in the posterior midbrain of Ap-2d-deficient mice. Despite the absence of
a central part of the auditory pathway, the presence of neuronal responses to sounds in the neocortex of Ap-2d-deficient
mice indicates that auditory information from the brainstem still reaches the neocortex. In summary, our data define Ap-2d
as an important transcription factor, specifying gene expression patterns required for the development of the posterior
midbrain.
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Introduction
Ap-2 transcription factors are closely related, sequence-specific
DNA-binding proteins that play pivotal roles in regulating gene
expression during development, differentiation, and tumorigenesis
[1]. In mammals, five Ap-2 genes (Tcfap2a to e) exist, which encode
for the Ap-2a to e proteins. Ap-2a, Ap-2b and Ap-2c show
partially overlapping expression patterns in neural crest cells, the
central and peripheral nervous system, the facial mesenchyme, the
limbs, various epithelia of the developing embryo, and the extra-
embryonic trophectoderm [2,3,4]. In contrast, the more recently
characterized Ap-2 transcription factors, Ap-2d and Ap-2e, show a
more restricted expression pattern and are almost exclusively
expressed in the central nervous system. Ap-2e was mainly found
in the developing olfactory bulb, the vomeronasal epithelium
[5,6], and hypertrophic chondrocytes [7], whereas Ap-2d is
predominantly expressed in the midbrain. In addition, Ap-2d is
expressed at lower levels in the diencephalon, forebrain, spinal
cord and the retina and for a short period in the developing heart
[8].
Until now all Ap-2 isoforms, except for Tcfap2d, have been
inactivated in mouse and their phenotypes indicate individual
and non-redundant functions during mouse development. Mice
lacking Ap-2a die perinatally with neural tube, limb mesenchyme
and craniofacial defects [9,10,11]. Ap-2b knockout mice develop
polycystic kidney disease and terminal renal failure and die shortly
after birth [12,13]. Ap-2c controls proliferation and differentiation
of extraembryonic trophectodermal cells and deficiency results in
early embryonic lethality due to defective implantation and nutri-
tion of the developing embryo [14,15]. A recent study on Ap-2e
deficient mice revealed disorganized neuronal lamination of the
olfactory bulb [16].
Ap-2 proteins have been reported to form homodimers as well
as heterodimers that bind to highly conserved GC-rich consensus
sequence present in many cellular and viral promoters and enhancers.
An in vitro binding site selection assay identified GCCN3/4GGC
and GCCN3/4GGG as the preferred sequence motifs bound by
Ap-2 transcription factors [17]. The Ap-2 family members share
a highly conserved basic DNA-binding domain and a carboxy-
terminal helix-span-helix motif that mediates DNA binding and
dimerization [18,19]. Ap-2d is considered the most divergent
family member because its transactivation domain lacks certain
amino acids, which are thought to play a critical role for its
transcriptional activity. Based on this observation it is believed
that Ap-2d interacts with a different set of coactivators and target
genes. To address the function of Ap-2d in vivo, we disrupted the
Tcfap2d gene in mice. Ap-2d-deficient mice are viable but lack
parts of the posterior midbrain due to massive apoptotic cell
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target gene screen from the posterior midbrain showed that
several transcription factors are regulated by Ap-2d suggesting
that the normal differentiation program of this structure is
disturbed in the absence of Ap-2d leading to programmed cell
death. Surprisingly, despite of the absence of the colliculus
inferior in Ap-2d-deficient mice neuronal responses to sounds
were recorded in the neocortex indicating that a different
auditory route towards the auditory cortex is used in Ap-2d-
knockout mice.
Materials and Methods
ES cell culture and generation of Ap-2d-null mice
The full-length Ap-2d cDNA was used to screen a Sv129 PAC
library. A 10.2 kb EcoRV fragment containing exons 1 to 3 of the
Tcfap2d gene was subcloned into pBluescript II SK (-) (Stratagene).
The targeting vector was designed to disrupt exon 1 by an inserted
IRES-b-Gal-neo cassette, flanked by 3.0 kb 59 homologous and
4.3 kb 39 homology arms according to (13). ES cells and Ap-2d
mutant mice were genotyped by Southern blot analyses (Fig. 1c) or
genomic PCR. For PCR analyses, a forward primer (59-AAT-
GCATCGTAAGCTTTTGGAG-39) was used in combination
with a reverse primer (59-GGAGGAGAGTTGCCCTCCCTG-
CG-39) to determine the wild-type allele, and a third primer (59-
CTGCTCTTTACTGAAGGCTCTTT-39) to detect the null
allele. Mice were kept at the MPI of Biochemistry animal facility
in accordance to Bavarian animal welfare laws. Generation of Ap-
2d deficient mice does not require permission of the Bavarian
animal protection law. The generation of Ap-2d deficient mice was
carried out in strict accordance with all German (e.g. German
Animal Welfare Act) and EU (e.g. Directive 86/609/EEC) appli-
cable laws and regulations concerning care and use of laboratory
animals. The Max Planck Institute of Biochemistry has a licence for
breeding and housing of laboratory animals (No. 5.1-568 - rural
districts office). This includes the generationof knockoutmice by ES
cells injection.For this kind of experimentsno separate licenceor an
approval of an ethics committee is required in the District Upper of
Bavaria. All animals used were bred for scientific purposes.
The Max Planck Institute of Biochemistry is registered at NIH
and has a PHS Approved Animal Welfare Assurance from the
Office of Laboratory Animal Welfare: #A5132-01. (see:http://
Figure 1. Generation and analysis of Ap-2d-defecient mice. (a) Radioactive in situ hybridization with an Ap-2d-specific probe on sagittal
sections of either whole embryos (E12-E16; A–C) or isolated brains (D–F) of newborns (NB; D) and three months old mice (3 mo; E, F). Ap-2d is mainly
expressed in the posterior mesencephalon (A–F) and weakly in the dorsal thalamus (A–D; white arrows B–D) (b) Schematic representation of the
partial Tcfap2d gene locus and the targeting construct. Black boxes indicate Tcfap2d exons 1 through 3 and the black box indicates the probe used
for Southern hybridization which recognizes the 10 kb wild-type and the 6.3 kb mutant Tcfap2d EcoRV fragment. (c) Southern blot analysis of tail
biopsy DNAs from the progeny of mating heterozygotes. (d, e) Confirmation of Tcfap2d gene deletion by RT-PCR analysis on cDNA of E17 posterior
midbrains extracted from wild-type (+/+), heterozygous (+/2) and Ap-2d-deficient mice (2/2) (d) and by X-Gal staining (e) on brains of newborns. In
brains from heterozygous animals, Ap-2d promoter activity can be detected in the posterior midbrain (arrowhead). In contrast, in Ap-2d-deficient
animals the LacZ staining is diffusely spread throughout the midbrain (arrowhead) (e).
doi:10.1371/journal.pone.0023483.g001
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In situ hybridization, whole mount in situ hybridization,
X-Gal staining, immunohistochemistry and
immunofluorescence staining
In situ hybridizations and whole-mount in situ hybridizations
were performed essentially as previously described [20,21]. For X-
Gal staining, brains were isolated, washed in 100 mM sodium-
phosphate buffer pH 7.3 and fixed in 0.2% glutaraldehyde, 5 mM
EGTA, 2 mM MgCl2 in 100 mM sodium-phosphate buffer
pH 7.3 for 30 min. Upon washing in 2 mM MgCl2, 0.02% NP-
40 in sodium-phosphate buffer pH 7.3, tissues were stained in X-
Gal staining solution (1 mg/ml X-Gal, 5 mM K4Fe(CN)6,5m M
K3Fe(CN)6 in wash buffer) for several hours at 37uC. Immuno-
histochemical analysis with the Ap-2d specific antiserum was
performed exactly as described [6]. Immunofluorescence staining
was performed using secondary antibodies from Molecular
Probes/Invitrogen.
RNA isolation, Affymetrix microarray procedures and
qRT-PCR
Micro-dissected posterior midbrains from 15 Ap-2d2/2 and
wild-type E15 embryos each were pooled and total RNA was
purified using the RNeasyMini-kit from Qiagen as specified by the
manufacturer. For microarray analyses, we used the Affymetrix
GeneChip platform employing a standard protocol for sample
preparation and microarray hybridization. Total RNA (2.5 mg)
was converted into biotinylated cRNA according to the Affymetrix
standard protocol version 2, purified, fragmented and hybridized
to Affimetrix GeneChip Mouse Genome xY 2.= ArraysHG-
U133Plus_2.0 microarrays (Affymetrix Inc.). The microarray data
has been released into the GEO-database (Accession Number
GSE27296).
Gene expression was monitored by quantitative real-time
PCR (Applied Biosystems). Expression values were normalized
to the mean of HPRT. Primer sequences are available upon
request.
Antiserum production and Western blot analysis
An Ap-2d specific peptide (GSQYGMHPDQRLLPG) was
coupled to Imject Maleimide Activated mcKLH (Pierce) and
used to immunize rabbits. Protein lysates were extracted from
cells, blotted and incubated as described [22]. Dilutions of the
antibodies: a-Ap-2d 1:5.000, a-HA (Hiss Diagnostics) 1:5000;
b-actin (Sigma-Aldrich) 1:20.000; a-tubulin (Abcam) 1:10.000.
Chromatin immunoprecipitation (ChIP)
ChIP experiments were performed essentially as described [23].
Neuro2a cells were transfected with an HA-Ap-2d expression
plasmid 2 days before harvesting for ChIP. Immunoprecipitation
was performed with specific antibodies to HA and IgG (Dia-
genode) as a negative control on protein A coupled Dynabeads
(Invitrogen). Amplicons were normalized to the DNA immuno-
precipitated with antibody to histone H3 (Abcam). Recovered
DNA was analyzed by TaqMan real-time PCR using the following
loci-specific primers: Bhlhb4 -300 bp: 59-AGAAATGGCAGTT-
GAGGGG-39,5 9-AATCAGAGGGGACCTGCTG-39, Bhlhb4 -
1.8 kB: 59-TCTCTTCCTAGCCTCCCACA-39,5 9-GCTGTTC-
AGGGGAGTCT GTC-39, Pou4f3 -2.6 Kb: 59-TGACCAT-
TGCTAGTGGACCTT-39,5 9-CCAATGCGGTTCA ACAG-
AC-39. Values were displayed as percent H3 with H3 occupancy
arbitrarily set to 100%.
Cell culture and transfection
Neuro2A cells were cultured in DMEM supplemented with
10% FCS. Transient transfection assays were carried out using the
standard calcium phosphate technique. Luciferase (LUC) activity
was assayed as recommended by the manufacturer (Promega) in
the Luminometer Centro LB 960 (Berthold). Relative light units
were normalized to protein concentration using the Bradford dye
assay (Bio-Rad). All experiments were repeated at least five times.
Reporter and expression plasmids
The LUC reporter plasmid Pou4f3 22.8 kb (BAC clone
(RPCIB731H07316Q, imaGenes)) and Bhlhb4–6 kb were gener-
ated using PCR amplification followed by insertion of the PCR
product into pGl3-basic (Promega). Bhlhb4–0.5 kb was generated
by subcloning of Bhlhb4–6 kb. Expression plasmid pSG5-Ap-2d
was generated by excision of Ap-2d cDNA from pCMX-Ap-2d
and insertion into pSG5 vector (Stratagene). For pSG5-HA-Ap-
2d, a cDNA fragment encoding Ap-2d downstream of an optimal
Kozak sequence and an HA tag was generated by PCR amplification
using pSG5-Ap-2dastemplate.All generated constructswere verified
by sequencing.
DNA binding studies
Ap-2d was in vitro translated using the TNT-coupled reticulocyte
extract (Promega). Ap-2d primed lysate was incubated with
approximately 0.8 ng of the
32P-labeled oligonucleotide probe
according to Zhao et al. [8]. Subsequently, the samples were
separated on 5% nondenaturing polyacrylamide gels in 0.256
TBE running buffer. Gels were dried and subjected to autoradi-
ography at 280uC. The following oligonucleotides were used:
Zhao 5-9GAACTGACCGCCTGAGGCGCGTGTGCA-39,5 -
9TGCACACGCGCCTCAGGCGG-TCAGTT-39, Pou wt 59-
TTTCTAGGGGC-CTGAGGGAAGTAGTGG-39, 5-‘CCACT-
ACTTCCCTCAGGCCC-3’, Pou mt1 59-TTTCTAGGGGC-
CAGTGGGAAGTAGTGG-39, 5-‘CCACTACTTCCCACTGG-
CCC-3’, Pou mt2 59-TTTCTAGGGGCCGTTGGG-AAGT-
AGTGG-39, 5-‘CCACTACTTCCCAACGGCCC-3’. To deter-
mine the composition of various DNA-protein complexes, the
following antibodies were included during incubation: a-Ap-2d
and rabbit a-IgG (Diagenode).
Recordings of neuronal responses from neocortex
Recordings were performed in the caudal part of the temporal
cortex of two anesthetized (Ketamin/Xylazin, 75 mg/kg/5 mg/
kg) Ap-2d2/2 mice in an acoustically and electrically shielded
recording chamber. Multiunit activity was recorded with tungsten
electrodes (WPI, TM 33A10KT, 1 MV impedance), amplified
(20,000 times), filtered (bandpass from 250–8,000 Hz), digitised
(40 kHz sampling at 12-bit resolution) and stored in a multichan-
nel recording system (Multichannel Acquisition Processor; Plexon).
Electrode penetrations were made perpendicular to the cortical
surface and recordings were obtained in a depth of 300–350 mm
from cortical layers III-IV from at least 10 neurons from Ap-2d2/2
mice and compared with those of wildtype animals. Acoustical
stimuli were digitally synthesized and controlled pure tones
(MathWorks) presented in pseudorandomized series of bursts
(200 ms duration, 5 ms rising and falling ramp, 600 ms inter-burst
interval) of frequencies with a logarithmic, iso-octave spacing
spanning 6 octaves from 1000 Hz to 64 kHz. Tone bursts were
delivered via an attenuator(gPAH, gtec,)and amplifier (PMA 1060,
Denon) to a loudspeaker (W06, Manger) positioned 30 cm in front
of the animal’s head. All tones were presented at a sound pressure
level (SPL) of 7065 dB at the ear of the animals. Significant
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above spontaneous activity level.
Statistical methods
Statistical significance was calculated using the Student’s
t-test. A p-value less than 0.05 was considered to be significant.
(* = p,0.05; ** = p,0.005; *** = p,0.0005)
Results
Generation of Ap-2d-deficient mice
Ap-2d is almost exclusively expressed in the central nervous
system [8]. A detailed analysis of Ap-2d expression during
development and in the postnatal brain was performed as a
prerequisite for the analysis of Ap-2d mutant mice. Therefore, we
visualized Ap-2d expression on sagittal sections of mouse embryos
and isolated brains of newborns and 3 months old mice,
respectively, using in situ hybridization. At E12.5 and E14.5,
Ap-2d localizes to the mesencephalic tectum and the dorsal
diencephalon (Fig. 1a, A–B). Already at E14.5 a more intense Ap-
2d signal becomes apparent in the posterior midbrain. This shift in
Ap-2d expression towards the posterior midbrain is even more
striking at later stages of development (Fig. 1a, C) and is completed
at the newborn stage (Fig. 1a, D). After birth the dorsal midbrain
separates into an anterior part, the colliculus superior, and a
posterior structure, the colliculus inferior. In the adult brain, Ap-
2d is predominantly expressed in the colliculus inferior (Fig. 1a, E,
F). Additionally, weak Ap-2d expression can be detected in the
dorsal thalamus and the forebrain both during embryogenesis and
adulthood (Fig. 1a white arrows).
To inactivate the Tcfap2d gene in mice we screened a PAC
library with an Ap-2d cDNA probe and isolated a 10-kb clone
spanning exons 1–3 of the gene (Fig. 1b). To disrupt the Ap-2d
coding sequence we inserted a b-galactosidase-neomycin cassette
into exon 1 of the Tcfap2d gene. Heterozygous Ap-2d mice (Ap-
2d+/2) are fertile and show no overt phenotype. A Southern blot
of wild-type, Ap-2d+/2 and Ap-2d-deficient (Ap-2d2/2) mice
confirmed the targeted mutation of the Tcfap2d gene locus (Fig. 1c).
Consistently, RT-PCR analysis with Ap-2d-specific primers on
RNA from posterior midbrains of E17.5 embryos verified a
significant reduction in Ap-2d expression in heterozygous mice
and the complete inactivation of the Tcfap2d gene in Ap-2d-
deficient mice (Fig. 1d). Next, we performed whole mount LacZ
stainings on brains from newborn wild-type, heterozygous and Ap-
2d deficient mice. In line with previous expression data, strong ß-
galactosidase activity, which indicates high Ap-2d promoter
activity, is present in the posterior midbrain and a much weaker
staining can be seen in the anterior midbrain and the
diencephalon of Ap-2d+/2 mice. In contrast, LacZ staining on
brains from Ap-2d-deficient mice did not show a discrete labelling
of the posterior midbrain but instead was diffusely spread
throughout the entire midbrain (Fig. 1e).
Ap-2d-deficient mice lack the colliculus inferior
We next wanted to know whether loss of Ap-2d affects brain
morphology. Sagittal sections through the brain of 6 weeks old Ap-
2d2/2 mice showed a normal organization into forebrain,
midbrain and hindbrain. However, the posterior midbrain, the
colliculus inferior, was missing in Ap-2d mutant mice (Fig. 2a,b).
In order to analyse Ap-2d function in more detail we generated an
isoform-specific Ap-2d antibody, that revealed a 50 kDa band in
HepG2 cells transfected with an Ap-2d cDNA but did not show
any crossreactivity with any other Ap-2 isoform (Figure S1a). Its
specificity was also confirmed by transfection experiments into
NIH3T3 cells and in immunohistological stainings on sections
from E13.5 embryos that revealed a nuclear staining in cells of the
diencephalon and midbrain, the two major regions in the
developing brain that are also labelled by whole mount in-situ
hybridizations of embryos hybridized with an Ap-2d-specific
cDNA probe (Figure S1 b–d). Using Ap-2d and Ap-2a-specific
antibodies on paraffin sections of adult wild-type brains mapped
Ap-2d expression to the colliculus inferior and, to a lesser extent,
to the dorsal thalamus and the colliculus superior (Fig. 2c).
Immunohistochemical staining of sagittal brain sections from Ap-
2d2/2 mice revealed no signal (Fig. 2d). In sharp contrast, Ap-2a
is not expressed in the colliculus inferior but strongly expressed in
the anterior dorsal midbrain, the colliculus superior, and the
cerebellum (Fig. 2e). Strikingly, the remaining dorsal midbrain of
Ap-2d2/2 animals is positive for Ap-2a indicating that indeed
the complete colliculus inferior is lacking in Ap-2d mutant mice
(Fig. 2f). The lack of the posterior midbrain might be either due to
a defect in its formation during development or due to degradation
in the absence of Ap-2d. To test whether Ap-2d is involved in the
formation of the posterior midbrain during development we
performed whole-mount in situ hybridizations with a set of marker
genes, which are known to play essential roles during midbrain-
hindbrain organization [24,25,26,27,28,29]. Marker genes includ-
ed Pax2, Pax5, Fgf8, En1, and Wnt1. Since no aberrant expression
of these marker genes can be observed in 10 days old Ap-2d-
deficient embryos compared to control embryos, we concluded
that Ap-2d is either not required for early midbrain development
or its loss can be compensated by the other Ap-2 transcription
factors at this early developmental stage (Figure S2).
Apoptosis leads to loss of colliculus inferior in Ap-2d-
deficient mice
Ap-2 transcription factors are known to suppress apoptotic
processes during embryogenesis [13]. Therefore, we investigated
whether an increased cell death in the developing brain is
responsible for the malformation. To this end, we examined
coronal sections of embryonic brains at E13.5 to 17.5 by
immunohistochemical staining for activated caspase 3 as a marker
for programmed cell death. While no apoptosis can be detected in
control and Ap-2d mutant brains at E13.5, single apoptotic cells
are labelled at E15.5 in the posterior midbrain of Ap-2d-deficient
mice. At E17.5 a dramatic increase in the number of apoptotic
cells can be detected in the posterior midbrain of Ap-2d mutants,
while no cell death can be observed in sections from control
embryos (Fig. 3a, middle and right column). To demonstrate that
the apoptotic region co-localizes with Ap-2d expression, consec-
utive wild-type sections were stained for Ap-2d showing that
indeed the region of apoptotic cell death overlaps with the
expression of Ap-2d in the posterior midbrain. These data indicate
that Ap-2d plays an essential role for the maintenance and further
maturation of the posterior midbrain and loss of Ap-2d results in
the degradation of this structure due to massive apoptosis (Fig. 3a,
right and left column).
Ap-2 isoforms cannot compensate Ap-2d deficiency in
the posterior midbrain
Ap-2d is also expressed in the anterior dorsal midbrain, the
dorsal thalamus and cortex (Fig. 1a). In contrast to the massive
apoptotic cell death in the posterior midbrain of Ap-2d mutants,
no apoptotic processes could be detected in these regions (data not
shown) suggesting that Ap-2d either plays a minor role for cell
survival in these structures or other Ap-2 isoforms can compensate
for its loss. Therefore, we analysed the expression of all Ap-2
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stainings with Ap-2-specifc antibodies indicate Ap-2a, Ap-2b, Ap-
2c and Ap-2d expression in the anterior dorsal midbrain but not in
the posterior midbrain, the colliculus inferior (Fig. 3b). We could
not detect any Ap-2e expression in the midbrain at this develop-
mental stage. Thus, Ap-2d represents the only Ap-2 isoform
expressed in the posterior midbrain at E17 and therefore its loss
cannot be compensated by any other Ap-2 isoforms.
Identification of Ap-2d target genes in the developing
posterior midbrain
To understand Ap-2d-dependent control of midbrain develop-
ment, we identified Ap-2d specific target genes that are involved in
the formation of this brain structure. We isolated mRNA from
wild-type and Ap-2d2/2 embryos at E15.5, shortly before tissue
destruction becomes evident, and compared the expression
patterns by microarray analysis. Using this approach we could
identify 12 genes that showed a more than 2-fold difference in
their expression levels between both samples (Fig. 4a). Quantita-
tive RT-PCR analysis from total RNA samples isolated from the
midbrains of E15.5 embryos verified their differential expression in
Ap-2d-deficient midbrain compared to wild-type tissue (Fig. 4b).
While most genes showed reduced expression, two genes, Rdh9
and Rgs4, showed an increased expression in the absence of Ap-
2d. Notably, four transcription factors, Pitx2, Mef2c, Bhlhb4 and
Pou4f3 were also identified as putative Ap-2d target genes. Whole
mount in situ hybridizations on E15.5 brains from control embryos
verified that they are expressed in the midbrain. Importantly, loss of
Ap-2d abolished expression of these genes in the midbrain, while
their expression patterns in other brain structures such as the
forebrain and thalamus for Mef2c and Pitx2, respectively, were not
altered (Fig. 4c).
Ap-2d binds to the Pou4f3 and Bhlhb4 promoter and
activates transcription
To assess the transcriptional regulatory potential of Ap-2d on
Bhlhb4 and Pou4f3, we performed transient transfections with
luciferase reporter constructs containing 6 kb and 500 bp frag-
ments of the Bhlhb4 promoter (Bhlhb4–6 kb and Bhlhb420.5 kb,
respectively) and a 2.6 kb fragment of the Pou4f3 promoter
(Pou4f322.6 kb) upstream of the LUC reporter gene. Neuro2A
cells endogenously express Ap-2d and assumingly present a source
of cofactors that might be indispensable for transactivation.
Cotransfection of an Ap-2d expression plasmid in Neuro2A cells
Figure 2. Histological analysis of wild-type and Ap-2d-deficient mesencephalon. (a, b) Hematoxylin-eosin staining on midbrain paraffin
sections of 1.5 months old mice. The arrows mark the colliculus inferior, which is absent in Ap-2d-deficient mice. (c–f) Immunohistological analysis
with Ap-2d (c, d) and Ap-2a (e, f) -specific antibodies on sagittal sections from 3 weeks old mice midbrains. Ap-2d expression is restricted to the
colliculus inferior and, to a lesser extent, to the colliculus superior and the dorsal thalamus. Ap-2a is expressed in the colliculus superior and the
cerebellum of wild-type animals. In Ap-2d-deficient mice, the expression of Ap-2a extends throughout the entire mesencephalon.
doi:10.1371/journal.pone.0023483.g002
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2.5-fold which is within the activating potential of Ap-2 proteins
(Fig. 5a).
Ap-2d occupies the Bhlhb4 and Pou4f3 promoter in vivo
To determine if Bhlhb4 and Pou4f3 are direct targets of Ap-2d
we performed chromatin immunoprecipitation (ChIP). We looked
for evolutionary conserved Ap-2 binding sites on genomic loci of
Bhlhb4 and Pou4f3 and found two putative binding sequences in
the Bhlhb4 promoter and one sequence in the Pou4f3 promoter.
ChIP was carried out on Neuro2a cells that had been transfected
with an HA-tagged Ap-2d expression plasmid or on untransfected
cells. By this approach we could demonstrate that Ap-2d occupies
the promoter of Bhlhb4 at the previously identified conserved
binding sites located 21.6 kb and 2300 bp upstream of the
transcriptional start site (TSS) (Fig. 5b upper panel). Furthermore,
Ap-2d is associated to the Pou4f3 promoter at a conserved
recognition sequence 2.8 kb upstream of the TSS (Fig. 5b lower
Figure 3. Massive apoptosis in colliculus inferior of Ap-2d-deficient mice. (a) Immunohistological detection of Ap-2d expression (left
column) and apoptosis (middle and right column) with an activated caspase 3 antibody on coronal sections of embryonic brains of different
developmental stages (E13-E17). Single apoptotic cells can be detected at E15 in the posterior midbrain of Ap-2d-deficient mice (arrows), whereas
massive apoptotic processes can be observed at E17. Right column: Indication of sectional plane through the brain. (b) Immunohistological
characterization of Ap-2 isoforms on sagittal sections of midbrains from wild-type mice. Ap-2a, Ap-2b, Ap-2c and Ap-2d are expressed in the anterior
midbrain (colliculus superior) of E17 embryos. Note that Ap-2d is exclusively expressed in the colliculus inferior. Boxed areas are shown in the right
panels. Expression of Ap-2e was not detected in the midbrain at this developmental stage.
doi:10.1371/journal.pone.0023483.g003
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PLoS ONE | www.plosone.org 6 August 2011 | Volume 6 | Issue 8 | e23483Figure 4. Identification of genes differentially expressed in the posterior midbrain of Ap-2d wild-type and knockout mice. (a) List of
differentially expressed genes in the posterior midbrain of E15 wild-type and Ap-2d knockout embryos obtained from microarray analysis. (b)
Validation of microarray data by real-time PCR. Relative expression levels of putative Ap-2d target genes were determined from three independent
qRT-PCR experiments, which were performed in triplicates. Data are presented as mean6SD. p-values (p,0.005) indicate significant differences from
wild-type for each gene. (c) In situ hybridizations on E15 brains from wild-type and Ap-2d-deficient embryos with specific cDNA probes of the
transcription factors Pitx2, Mef2c, Bhlhb4 and Pou4f3. Shown are lateral (top), dorsal (middle) and ventral (below) views.
doi:10.1371/journal.pone.0023483.g004
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PLoS ONE | www.plosone.org 7 August 2011 | Volume 6 | Issue 8 | e23483Figure 5. Ap-2d binds to the Bhlhb4 and the Pou4f3 promoter. (a) Luc reporter plasmids were cotransfected with an Ap-2d expression
plasmid into Neuro2A cells. Ap-2d activates native promoters of Bhlhb4 and Pou4f3 for more than 2.5-fold. The bars represent relative luciferase units
normalized to total protein and show the mean 6 s.e.m. of three independent transfections. Reporter-only transfections (pGl3-basic) were set at 1. p-
values indicate significant differences from reporter-only transfected cells (student’s t-test). (b) ChIP/qPCR assays in wild-type and HA-Ap-2d
transfected Neuro2a cells. (Top) Ap-2d binds to the Bhlhb4 promoter 1.8 kb and 300 bp upstream of the TSS. (Bottom) Ap-2d occupies the Pou4f3
promoter 2.8 kb upstream of the TSS. Bars represent mean abundance 6 s.e.m. relative to histone H3 as determined from triplicate PCR
measurements. p-values indicate significant differences from HA-Ap-2d transfected Neuro2a cells precipitated with an anti-HA antibody compared to
non-transfected Neuro2a cells or IgG treated lysates (student’s-test) (c) (Top) EMSA was performed by incubating
32P-labeled, binding site-containing
oligonucleotides with in vitro-translated Ap-2d protein. The Ap-2d/DNA complex is specifically supershifted with an a-Ap-2d antibody and competed
using an 80-fold excess of unlabeled oligonucleotide. (Bottom) EMSA was performed with an oligonucleotide containing the wildtype binding site of
the Pou4f3 promoter (core sequence: GCC TGA GGG) or mutated forms (Pou mt1: GCC AGT GGG, Pou mt2: GCC GTT GGG). Upon mutation of the
binding site, Ap-2d binding is abolished.
doi:10.1371/journal.pone.0023483.g005
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in untransfected cells or after immunoprecipitation with the
control antibody (Fig. 5b).
Direct binding of Ap-2d to the Pou4f3 promoter
Ap-2 proteins bind to the evolutionary conserved binding sites
GCCN3/4GGC or GCCN3/4GGG. Zhao et al. could show that Ap-
2d specificallybindstoa sequencewithTGA asthepreferredcentral
3 bpspacerbetweenthepalindromicGCCmotifs[8].Thesequence
in the Pou4f3 promoter that we found to be occupied by Ap-2d
fulfills these criteria. We therefore investigated the direct binding of
Ap-2d protein to this sequence using electrophoretic mobility shift
assays. In vitro translated Ap-2d protein formed protein/DNA
complexes with both oligonucleotides containing either the
optimized Ap-2 binding site from Zhao et al. or the native binding
site of the Pou4f3 promoter (Fig. 5c top, lanes 2 and 7). The
complexes were supershifted by an a-Ap-2d antibody but not an
unrelated rIgG antibody (Fig. 5c top, lanes 3 and 8; Fig. 5c bottom,
lanes 3 and 4). The retarded Ap-2d/DNA complex is competed by
an 80-fold molar excess of unlabeled oligo (lanes 4 and 5; 9 and 10).
To analyze specificity of binding we introduced two mutations inthe
central 3 bp spacer. Mutation of the consensus sequence completely
abolished Ap-2d binding (Fig. 5c bottom). These data indicate that
Ap-2d binds to the Pou4f3 promoter in a specific manner.
Loss of Ap-2d results in downregulation of Pou4f3 target
genes
Since loss of Ap-2d leads to a significant downregulation of
Pou4f3 transcription, we hypothesized that Ap-2d deficiency might
also have an effect on Pou4f3 target genes [30,31]. Therefore, we
quantified steady-state mRNA levels of Pou4f3-regulated genes in
posterior midbrain samples of wild-type and Ap-2d2/2 mice.
Pou4f3 transcript levels in Ap-2d-deficient samples were reduced
to less than 20% of wild-type levels. Consistently, we also observed
a significant downregulation of Bdnf and Calbindin2, two Pou4f3
target genes; however, the expression of Lhx3, another Pou4f3
target gene, is not altered in Ap-2d-deficient posterior midbrains
(Figure S3).
Electrophysiological recordings from neocortical neurons
of Ap-2d2/2 mice
Since the colliculus inferior represents a central unit within the
auditory pathway, we tested whether its absence impairs the
transfer of auditory signals from the brainstem towards the
neocortex in Ap-2d2/2 mice. Neurons in the caudal temporal
cortex of two tested Ap-2d2/2 animals showed responses to tone
bursts despite absence of the colliculus inferior. The example of a
multi-unit recording in the raster-plot (Fig. 6a) shows a phasic
response to tones in a limited frequency range. Fig. 6b clearly
indicates an increased response rate in a frequency range between
3.4 and 16 kHz. The other recordings also showed phasic
responses to tones tuned to certain frequency ranges altogether
covering the range from 2.8 to 32 kHz. These data indicate that
strong auditory responses are present at the neocortical level. For
comparison a raster-plot of a multi-unit recording from a wild-type
animal is shown in Fig. 6c, d. Responses from wild-type neurons
also cover a certain frequency range (in this case 4 to 38 kHz) and
are often phasic responses. Spike waveforms are shown in the
insets (Fig. 6 a, c).
Discussion
In this study, we analyzed the in vivo function of Ap-2d by
targeted inactivation of the Tcfap2d gene in mice. Using brain
tissue from control and mutant mice we were able to compare
their transcriptomes and identify Ap-2d regulated genes. Ap-2
transcription factors have been found to be expressed in
ectodermal, neuroectodermal and mesodermal tisses, where they
are involved in controlling various developmental processes. In
contrast to the broad expression patterns of Ap-2a to c, the last
two members of the Ap-2 transcription family, Ap-2d and e, show
an almost neuronal specific expression pattern. Interestingly, all
five members of the Ap-2 family are expressed in the roof of the
midbrain during development. Ap-2d, however, shows a highly
dynamic expression pattern, in which it becomes enriched in the
posterior midbrain and declines in the anterior midbrain. A similar
expression pattern has not been described for any other Ap-2
transcription factor. Furthermore, beside its strong presence in the
posterior dorsal midbrain, none of the other Ap-2 isoforms were
found to be expressed there at the newborn stage, suggesting that
Ap-2d plays a pivotal role in this particular brain region. In line
with this hypothesis, inactivation of Ap-2d results in the degra-
dation of the posterior midbrain and the absence of the colliculus
inferior. Obviously, the initial organization and expansion of cells
of the midbrain/hindbrain region is not affected by the absence of
Ap-2d as the expression of a number of marker genes did not
show any alterations, although Ap-2d is already expressed at this
developmental stage. This suggests that the early midbrain
formation is not dependent on Ap-2d or its function is redundant,
possibly through compensation by the expression of the other Ap-2
isoforms. However, massive apoptotic cell death occurs at the end
of embryogenesis when Ap-2d remains as the only expressed Ap-2
isoform.
Ap-2 proteins are involved in the suppression of apoptotic cell
death in multiple developmental processes. Ap-2a to c knockout
mice reveal apoptotic processes at the main expression loci when
compensation by other Ap-2 proteins was not given. Ap-2a
mutant mice exhibited enhanced apoptosis in the anterior mid-
and hindbrain and in the proximal mesenchyme of the first
branchial arch [10]. We have demonstrated before that a decrease
in expression of the anti-apoptotic genes bcl-XL, bcl-w and bcl-2
preceded massive apoptotic cell death in kidneys of Ap-2b-
deficient mice [13]. Furthermore, cultured trophoblast cells of Ap-
2c-deficient blastocysts showed signs of morphological and
apototic changes as well as a reduced expression of adenosine
deaminase (ADA) [15]. These data show an essential role for Ap-2
transcription factors for the differentiation and survival of various
different cell types.
Beside itsrolein suppressingcell death, Ap-2 transcription factors
are key molecules that control cell differentiation by specifying
target gene expression patterns. Chen et al. [32] reported that Ap-2
together with Sp-1 mediated differentiation by regulating K3
keratin transcription. A low Sp1/Ap-2 ratio accounted for sup-
pression of K3 in undifferentiated basal cells whereas a high Sp1/
Ap-2 ratio accounted for activation of K3 in differentiated corneal
epithelial cells [32]. To analyse which target genes are controlled by
Ap-2d in the posterior midbrain we performed microarray analysis.
Among the 12 putative targets four transcription factors were found
which showed significant reduction in their expression. Whole
mount in situ hybridization verified that Pitx2, Mef2c, Bhlhb4 and
Pou4f3 are expressed in the midbrain of wild-type mice, but upon
deletion of Ap-2d the expression of these transcription factors was
not detectable anymore in this brain structure. These data indicate
that Ap-2d is a central, higher order transcription factor that
controls neuronal differentiation by controlling other transcription
factors.
Functional classification of our genes downregulated in the
absence of Ap-2d revealed also genes involved in immunoregulation
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controlling muscle development and contraction (Mef2c, Myh8),
signal transduction (Rgs4) and metabolism (Ndst4, Rdh9) were
found to be differentially expressed. Ap-2d ablation also resulted in
the significant downregulation of Pitx2 in the posterior midbrain.
Notably, the promoter of the Pitx2 isoform, Pitx2c, is occupied and
activated by Cited2 and Ap-2a in the heart [33]. So Pitx2c is a
target of Ap-2a in the heart, however, which Pitx2 isoform is
regulated by Ap-2d in the midbrain remains to be analyzed.
Our in vivo Ap-2d target gene screen was conducted on posterior
midbrain samples of Ap-2d-deficient animals. In contrast, previous
studies analyzed Ap-2d target gene expression after exogenous
Figure 6. Comparison of neuronal response to tone stimulation from the neocortex of an Ap-2d2/2 and a wild-type mouse.
(a) Raster plot from an Ap-2d2/2 mouse showing action potential (dots) of a small group of neurons that responded with an increased firing rate to
the onset of tones of frequencies between 3.4 and 16 kHz. Each horizontal row of dots represents a trial with 15 trials per presented frequency
(y-axis). The grey area covers the stimulus duration. The inset shows the spike waveforms of the recording. (b) The tone-evoked spike rate from (a) is
plotted as a function of the stimulus frequency. Grey shade shows the standard error of the mean of the evoked rate, the dashed line the level of the
spontaneous rate. The tone-evoked rate of the neuronal response is significantly higher than the spontaneous rate indicating auditory activity in the
cortex. (c, d) Raster-plot (c) and rate function (d) from a wildtype mouse showing increased firing rate to the tone onset in a similar frequency range (4
to 38 kHz) as in Ap-2d2/2 mouse.
doi:10.1371/journal.pone.0023483.g006
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Neuro2a cells, respectively [34,35]. Our approach was performed
to directly identify Ap-2d target genes in vivo, which was also
verified by qRT-PCR and in situ hybridizations, however, it is
limited to genes expressed in the posterior midbrain.
Importantly, our data clearly show that Ap-2d physically
occupies in a sequence-specific manner an Ap-2-binding site
located in the Pou4f3 promoter. Mutation of the binding site
completely abolished Ap-2d binding indicating high specificity.
Pou4f3 plays an essential role in cell maturation and survival of
cochlear hair cells in inner ear sensory epithelia. Pou4f32/2 mice
suffer from defective inner ear function as a result of complete
depletion of hair cells with subsequent loss of sensory neurons
[36,37]. Mutations of the POU4F3 gene have been related to
autosomal dominant nonsyndromic hearing impairment DFNA15
in humans [38]. It remains to be shown, whether Ap-2d is
expressed in inner ear hair cells to control Pou4f3 expression.
The central auditory system processes the sound information
from the inner ear via various nuclei in the brainstem towards the
inferior colliculus (IC) of the midbrain. The central nucleus of the
IC represents a relay station and sends the information to the
thalamus. In mammals the auditory information is further
processed in the medial geniculate body (MGB) of the thalamus,
which sends projections to the auditory cortex. Interestingly, these
auditory connections are already developed in mice before the
onset of hearing indicating that molecular genetic clues determine
the nuclear connections [39]. Although the colliculus inferior is a
central unit of the auditory pathway [40], sounds evoked cortical
neuronal responses in Ap-2d2/2 mice missing this nucleus. Our
results demonstrate that tone-evoked responses occurred in
temporal patterns and frequency tuning very similar to those
recorded in the auditory cortex of wild-type mice under the same
anesthetic conditions [41][42]. Thus it seems that at least some
higher auditory function beyond lower brainstem reflexes is
preserved in Ap-2d2/2 mice. The fact that Ap-2d2/2 mice are
able to process sounds at the neocortical level suggests that
substantial and still to be determined, compensatory mechanisms
during development must take place, e.g. bypassing the colliculus
inferior in the ascending auditory pathways to the cortex and
substituting its functional role. Alternatively, an auditory pathway
bypassing the inferior colliculus has been described in bats and
cats. This pathway visualized in the mustache bat originates in the
nucleus of the central acoustic tract (NCAT), a group of large cells
near the superior olive of the lower brainstem, ascends medial to
the lateral lemniscus, and courses beneath the inferior colliculus
and medial to the brachium of the inferior colliculus to reach the
deep layers of the superior colliculus and the suprageniculate
nucleus [43][44]. The central acoustic tract might explain the
simple response to individual tones in the auditory cortex in Ap-
2d-deficient mice. However, in which regard more complex pro-
cessing tasks are affected in the absence of the inferior colliculus
still needs to be determined. Accordingly, auditory function should
be further analyzed using auditory discrimination learning tests.
The Ap-2d2/2 mouse provides an excellent animal model to
study higher auditory functions based on neuronal plasticity in the
absence of the colliculus inferior. In addition, we and recently
published ISH in Eurexpress could show that besides the pro-
minent expression of Ap-2d in the posterior midbrain, Ap-2d is
also expressed in the diencephalon, possibly the medial geniculate
body (MGB), at moderate levels (www.eurexpress.org; assay ID:
euxassay_007907). As already indicated,,the MGB is a thalamic
relay station between the inferior colliculus and the auditory
cortex. Therefore, further studies have to be conducted to study
thalamocortical connections in Ap-2d knockout mice.
In summary, we here provide evidence that Ap-2d is essential
for the suppression of apoptotic cell death in the posterior
midbrain as depletion of Ap-2d results in the loss of the colliculus
inferior. Furthermore, we identify Bhlhb4 and Pou4f3 along with a
set of other candidates as de novo Ap-2d target genes and thus, our
data define molecular mechanisms controlling development of the
posterior midbrain by Ap-2d.
Supporting Information
Figure S1 Characterization of an Ap-2d-specific polyclonal
antibody raised against an N-terminal peptide. (a) Western blot
analysis of protein extracts of HepG2 cells transfected with
expression plasmids of all Ap-2 isoforms. The antibody specifically
recognizes the 50 kDa Ap-2d protein in cells transfected with an
Ap-2d expression plasmid without any cross reactivity with other
Ap-2 isoforms. Anti-tubulin staining indicates equal loading.
(b) Immunofluorescence stainings of NIH-3T3 cells co-transfected
with an Ap-2d expression plasmid and an EGFP-containing
plasmid. EGFP-positive cells showed a nuclear staining after Ap-
2d-specific antibody incubation. (c) Whole mount in situ
hybridization with an Ap-2d-specific probe on E12.5 old embryos
maps Ap-2d expression to the midbrain (arrow) and the dorsal
thalamus (arrowhead). (d) Immunohistological staining using the
Ap-2d antibody on sagittal sections of E12.5 old embryos detects
Ap-2d protein in the midbrain (arrow) and dorsal thalamus
(arrowhead).
(TIF)
Figure S2 No defect in initial organization of midbrain. Whole
mount in situ hybridization of 10 days old wild-type and Ap-2d-
deficient embryos with specific digoxigenin-labeled probes of
marker genes characterizing midbrain-hindbrain organization
during embryogenesis. The non-aberrant expression pattern of
marker genes between wild-type and Ap-2d-specific embryos
indicates correct initiation of mid- and hindbrain formation.
(TIF)
Figure S3 Real-time qPCR analysis on Pou4f3-regulated
genes after knockout of Ap-2d. Total RNA was extracted from
the posterior midbrain of wild-type and Ap-2d knockout mice
at E15. Expression levels were normalized to HPRT. Note that
Ap-2d knockout led to a significant decrease of Bdnf and Calb2,
whereas steady-state level of Lhx3 is not affected by the loss of
Ap-2d. Statistical significance was calculated using the Student’s
t-test. A p-value less than 0.05 was considered to be significant.
(* = p,0.05; ** = p,0.005; *** = p,0.0005)
(TIF)
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